Data as of Jul 30
| +0.0246 / +1.20%|
The 1 analysts offering 12-month price forecasts for Echo Therapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a -3.38% decrease from the last price of 2.07.
The current consensus among 2 polled investment analysts is to Hold stock in Echo Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.